The SUMOylation of TAB2 mediated by TRIM60 inhibits MAPK/NF-κB activation and the innate immune response
Zhiwen Gu(Shanghai Institute of Materia Medica), Hongbo Hu(Sichuan University), Yanqiu Gong(Sichuan University), Shiqian Qi(Sichuan University), Lunzhi Dai(Sichuan University), Xueying Chen(Novartis (United States)), Wenyong Yang(Sichuan University), Zhiqiang Zhang(Houston Methodist), Qianqian Chen(Sichuan University), Xiaomeng Wang(Wuhan University), Hui Yu(Sichuan University), Bo Zhong(Wuhan University), Yu Qi(Sichuan University), Huiyuan Zhang(Chengdu University of Technology)
Cited by 32
Related Papers
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
|Signal Transduction and Targeted Therapy|2020|2k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag
|Journal of Virology|2005|265
TRIM29 promotes DNA virus infections by inhibiting innate immune response
|Nature Communications|2017|244